Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report

Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report

Source: 
Fierce Pharma
snippet: 

Federal prosecutors turned up the heat in recent months on a generic price-fixing probe that targeted some of the industry's biggest players before COVID-19 slowed the hunt. Teva, the biggest target in that investigation, has reportedly bailed on settlement talks in a decision meant to test the government's resolve.